Short Link N Modulates Inflammasome Activity in Intervertebral Discs Through Interaction with CD14
Biomolecules · 16.10.2024 · 14 (10) · 1312
DOI: 10.3390/biom14101312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 16.10.2024. Verfasst von Muskan Alad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical and Interventional Sciences, McGill University, Montreal, QC H3T 1E2, Canada. Hauptthemen laut MEDLINE: Lipopolysaccharide Receptors, Inflammasomes, Interleukin-1beta, Intervertebral Disc. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research (CIHR).
Abstract (Originalsprache)
Intervertebral disc degeneration and pain are associated with the nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing 3 (NLRP3) inflammasome activation and the processing of interleukin-1 beta (IL-1β). Activation of thehm inflammasome is triggered by Toll-like receptor stimulation and requires the cofactor receptor cluster of differentiation 14 (CD14). Short Link N (sLN), a peptide derived from link protein, has been shown to modulate inflammation and pain in discs in vitro and in vivo; however, the underlying mechanisms remain elusive. This study aims to assess whether sLN modulates IL-1β and inflammasome activity through interaction with CD14. Disc cells treated with lipopolysaccharides (LPS) with or without sLN were used to assess changes in Caspase-1, IL-1β, and phosphorylated nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB). Peptide docking of sLN to CD14 and immunoprecipitation were performed to determine their interaction. The results indicated that sLN inhibited LPS-induced NFκB and Caspase-1 activation, reducing IL-1β maturation and secretion in disc cells. A significant decrease in inflammasome markers was observed with sLN treatment. Immunoprecipitation studies revealed a direct interaction between sLN and the LPS-binding pocket of CD14. Our results suggest that sLN could be a potential therapeutic agent for discogenic pain by mitigating IL-1β and inflammasome activity within discs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical and Interventional Sciences, McGill University, Montreal, QC H3T 1E2, Canada.
- Orthopaedic Research Laboratory, Lady Davis Institute for Medical Research, Montreal, QC H3T 1E2, Canada.
- SMBD-Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
- Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada.
- Chemical Engineering Department, Polytechnique Montréal, Montreal, QC H3C 3A7, Canada.
- Department of Bioengineering, University of Illinois Chicago, Chicago, IL 60612, USA.
ORCID-Profile: Michael P Grant, Geraldine Merle, Hee-Jeong Im
Förderung
- Canadian Institute of Health Research (CIHR)
Zitieren
APA
Alad, M., Grant, M. P., Epure, L. M., Shih, S. Y., Merle, G., Im, H. J., Antoniou, J., & Mwale, F. (2024). Short Link N Modulates Inflammasome Activity in Intervertebral Discs Through Interaction with CD14. Biomolecules, 14(10), 1312. https://doi.org/10.3390/biom14101312
Vancouver
Alad M, Grant MP, Epure LM, Shih SY, Merle G, Im HJ, et al. Short Link N Modulates Inflammasome Activity in Intervertebral Discs Through Interaction with CD14. Biomolecules. 2024;14(10):1312. doi:10.3390/biom14101312
BibTeX
@article{Alad2024,
author = {Alad, Muskan and Grant, Michael P and Epure, Laura M and Shih, Sunny Y and Merle, Geraldine and Im, Hee-Jeong and Antoniou, John and Mwale, Fackson},
title = {Short Link N Modulates Inflammasome Activity in Intervertebral Discs Through Interaction with CD14},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {10},
pages = {1312},
doi = {10.3390/biom14101312}
}
EUVIMED